The Latest: UN-backed vaccine program expects supply delays

GENEVA — The U.N.-backed program to ship COVID-19 vaccines worldwide has announced supply delays for up to 90 million doses from an Indian manufacturer.

It’s a major setback for the ambitious rollout aimed to help low- and middle-income countries fight the pandemic. Gavi, the Vaccine Alliance, says the delays come as India is facing a surge of coronavirus infections that will increase domestic demands on the Serum Institute of India, a pivotal vaccine maker behind the COVAX program.

The move will affect up to 40 million doses of the AstraZeneca vaccines being manufactured by the Serum Institute that were to be delivered for COVAX this month, as well as 50 million expected next month.

Gavi, which runs COVAX jointly with the World Health Organization and the Coalition for Epidemic Preparedness Innovations, has already distributed 31 million doses of the AstraZeneca vaccine. There’s been 28 million from the Serum Institute and another 3 million from a South Korean contractor producing the vaccine.

___

THE VIRUS OUTBREAK:

— Biden doubles goal of COVID vaccines to 200 million doses

— 1 report, 4 theories: Scientists mull clues on virus’ origin

— Vaccination race enlists grassroots aides to fight mistrust

— Follow AP’s pandemic coverage at https://apnews.com/hub/coronavirus-pandemic, https://apnews.com/hub/coronavirus-vaccine and https://apnews.com/UnderstandingtheOutbreak

___

HERE’S WHAT ELSE IS HAPPENING:

LONDON — British lawmakers are voting on whether to prolong coronavirus emergency measures that have...